Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine

European Journal of Pharmacology

Volumn 373, Issue 2-3, 1999, Pages 187-193

  Izenwasser, Sari ^a,b   Coy, Abigail E ^a   Ladenheim, Bruce ^a   Loeloff, Richard J ^a   Cadet, Jean Lud ^a   French, Dawn ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; Dopamine; Methylphenidate; Transporter

Indexed keywords

COCAINE; DOPAMINE TRANSPORTER; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG BINDING; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; RAT;

ANIMALS; BINDING, COMPETITIVE; CARRIER PROTEINS; CAUDATE NUCLEUS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; INFUSION PUMPS; INJECTIONS, SUBCUTANEOUS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METHYLPHENIDATE; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NUCLEUS ACCUMBENS; PUTAMEN; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TEGMENTUM MESENCEPHALI; TIME FACTORS;

EID: 0032981740     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00274-5     Document Type: Article

References (22)

1. Carroll F.I., Kotian P., Dehghani A., Gray J.L., Kuzemko M.A., Parham K.A., Abraham P., Lewin A.H., Boja J.W., Kuhar M.J. Cocaine and 3Beta-(4′-substituted phenyl)tropane-2Beta-carboxylic acid ester and amide analogues. New high-affinity and selective compounds for the dopamine transporter. J. Med. Chem. 38:1995;379-388.
2. Deutsch H.M., Schweri M.M. Can stimulant binding and dopamine transport be differentiated? Studies with GBR 12783 derivatives. Life Sci. 55:1994;115-120.
3. Gaytan O., Ghelani D., Martin S., Swann A., Dafny N. Dose response characteristics of methylphenidate on different indices of rats' locomotor activity at the beginning of the dark cycle. Brain Res. 727:1996;13-21.
4. Gaytan O., al-Rahim S., Swann A., Dafny N. Sensitization to locomotor effects of methylphenidate in the rat. Life Sci./Pharmacol. Lett. 61:1997;101-107.
5. Gaytan O., Ghelani D., Martin S., Swann A., Dafny N. Methylphenidate: diurnal effects on locomotor and stereotypic behavior in the rat. Brain Res. 777:1997;1-12.
6. Inada T., Polk K., Purser C., Hume A., Hoskins B., Ho I.K., Rockhold R.W. Behavioral and neurochemical effects of continuous infusion of cocaine in rats. Neuropharmacology. 31:1992;701-708.
7. 3H ]dopamine uptake in vitro in rat nucleus accumbens but not in striatum Brain Res. 531:1990;338-341.
8. Izenwasser S., Cox B.M. Inhibition of dopamine uptake by cocaine and nicotine: tolerance to chronic treatments. Brain Res. 573:1992;119-125.
9. Izenwasser S., Werling L.L., Cox B.M. Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex. Brain Res. 520:1990;303-309.
10. Izenwasser S., French D., Carroll F.I., Kunko P.M. Continuous infusion of selective dopamine uptake inhibitors or cocaine produces time-dependent changes in rat locomotor activity. Behav. Brain Res. 99:1999;201-208.
11. Kalivas P.W., Duffy P., DuMars L.A., Skinner C. Behavioral and neurochemical effects of acute and daily cocaine administration in rats. J. Pharmacol. Exp. Ther. 245:1988;485-492.
12. King G.R., Joyner C., Ellinwood E.H. Jr. Continuous or intermittent cocaine administration: effects of flupenthixol treatment during withdrawal. Pharmacol. Biochem. Behav. 49:1994;883-889.
13. Kunko P.M., Loeloff R.J., Izenwasser S. Chronic administration of GBR 12909, but not cocaine, produces marked decreases in dopamine transporter density. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:1997;562-569.
14. Kunko P.M., French D., Izenwasser S. Alterations in locomotor activity during chronic cocaine administration: effect on dopamine receptors and interaction with opioids. J. Pharmacol. Exp. Ther. 285:1998;277-284.
15. McNamara C., Davidson E., Schenk S. A comparison of the motor-activating effects of acute and chronic exposure to amphetamine and methylphenidate. Pharmacol. Biochem. Behav. 45:1993;729-732.
16. Mueller K. Locomotor stereotypy is produced by methylphenidate and amfonelic acid and reduced by haloperidol but not clozapine or thioridazine. Pharmacol. Biochem. Behav. 45:1993;71-76.
17. Pan D., Gatley S.J., Dewey S.L., Chen R., Alexoff D.A., Ding Y.-S., Fowler J.S. Binding of bromine-substituted analogs of methylphenidate to monoamine transporters. Eur. J. Pharmacol. 264:1994;177-182.
18. Post R.M., Rose H. Increasing effects of repetitive cocaine administration in the rat. Nature (London). 260:1976;731-732.
19. Reith M.E.A., Benuck M., Lajtha A. Cocaine disposition in the brain after continuous or intermittent treatment and locomotor stimulation in mice. J. Pharmacol. Exp. Ther. 243:1987;281-287.
20. Rocha B., Fumagalli F., Gainetdinov R., Jones S., Ator R., Giros B., Miller G., Caron M. Cocaine self-administration in dopamine-transporter knockout mice. Nature Neurosci. 1:1998;132-137.
21. Segal D.S., Kuczenski R. Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Res. 577:1992;351-355.
22. Volkow N.D., Ding Y.-S., Fowler J.S., Wang G.-J., Logan J., Gatley J.S., Dewey S., Ashby C., Lieberman J., Hitzemann R., Wolf A.P. Is methylphenidate like cocaine? Arch. Gen. Psychiatry. 52:1995;456-463.